GlaxoSmithKline chief executive Andrew Witty has outlined ambitious proposals to help improve global public health through a different approach to intellectual property, pricing in poor countries and tackling diseases prevalent in developing areas.In a speech...

Sarah Boseley, Drug giant GlaxoSmithKline pledges cheap medicine for world's poor, The Guardian, February 13, 2009.The world's second biggest pharmaceutical company is to radically shift its attitude to providing cheap drugs to millions of people in the developing...